M&A Activity • Jul 1, 2025
M&A Activity
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 1620P
Geiger Counter Ltd
01 July 2025
THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED
Geiger Counter Limited (or the "Company")
1 July 2025
Entry into Standstill Agreement
The Company is pleased to announce that, following constructive engagement with Saba Capital Management, L.P. ("Saba"), it has agreed the terms of a Standstill Agreement.
Under the terms of the Standstill Agreement, Saba has agreed, amongst other things: that Saba shall not, and shall procure that its affiliates shall not, during the Standstill Period (i) require the Board to convene a general meeting of the Company pursuant to Jersey law; or (ii) exercise any voting rights available to remove, or publicly propose the removal of, any member of the Board. In addition, until the expiry or termination of the Standstill Period, Saba shall not, and shall use its reasonable endeavours to procure that its affiliates shall not, vote against the recommendation of the Board on specified ordinary course resolutions proposed at a general meeting or annual general meeting of the Company.
The Standstill Agreement shall have effect until the earliest of (i) the Company's AGM in 2028 or (ii) any earlier winding up, liquidation or voluntary corporate reconstruction of the shares and assets of the Company.
Enquiries
| Manulife | CQS Investment Management | Craig Cleland | T: +44 (0) 20 7201 5368 |
| Cavendish Capital Markets Limited | Tunga Chigovanyika (Corporate Finance) |
T: +44 (0) 20 7397 1915 |
| Daniel Balabanoff / Pauline Tribe (Sales) | T: +44 (0) 20 7220 0500 | |
| R&H Fund Services (Jersey) Limited | Jane De Barros | T :+44 (0) 1534 825 259 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGREAKXFEANSEEA
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.